U.S. markets open in 9 hours 17 minutes
  • S&P Futures

    -5.50 (-0.13%)
  • Dow Futures

    -28.00 (-0.08%)
  • Nasdaq Futures

    -16.75 (-0.12%)
  • Russell 2000 Futures

    -9.70 (-0.43%)
  • Crude Oil

    -0.25 (-0.41%)
  • Gold

    +0.30 (+0.02%)
  • Silver

    +0.01 (+0.02%)

    -0.0001 (-0.01%)
  • 10-Yr Bond

    +0.0020 (+0.13%)
  • Vix

    -1.18 (-6.32%)

    +0.0004 (+0.03%)

    -0.0530 (-0.05%)

    -2,288.57 (-4.08%)
  • CMC Crypto 200

    -21.19 (-1.68%)
  • FTSE 100

    +35.42 (+0.52%)
  • Nikkei 225

    +547.38 (+1.92%)

LED Medical Diagnostics Signs Exclusive Canadian Distribution Agreement With Samsung's Ray Co. and Receives Health Canada Approval for Panoramic, Cephalometric and Intraoral Capabilities

BURNABY, BC--(Marketwired - December 08, 2014) - LED Medical Diagnostics Inc. (TSX VENTURE: LMD) (LEDIF) (LME.F) ("LED Medical" or "the Company") is pleased to announce that, as of December 5, 2014, LED Dental Inc., ("LED Dental"), the wholly-owned Canadian operating subsidiary of LED Medical, has signed an exclusive one-year distribution agreement with Ray Co., Ltd. ("Ray Co."), a subsidiary of Samsung, to market the RAYSCAN Alpha - Expert dental imaging system and the RIOSensor intraoral sensor in Canada. The RAYSCAN Alpha - Expert is a multi-function digital extraoral imaging system with 3D cone beam computed tomography (CBCT) as well as panoramic and cephalometric capabilities. In April, the RAYSCAN Alpha - Expert dental imaging system became the first product to be added to LED Dental's product portfolio since the Company announced its expansion into the dental imaging category and emergent product offerings.

The RAYSCAN Alpha - Expert's 3D images are captured using an optimal field of view, which is ideal for a wide variety of clinical applications. The system's CMOS and direct deposition cesium iodide (CsI) detector ensure practitioners can quickly capture high-quality, 16-bit DICOM images. To minimize error from patient positioning and movement, the system's focal trough is stabilized and controlled through Adaptive Moving Focus technology. The RAYSCAN Alpha's exclusive denoising technology enhances image quality by removing noise that would otherwise blur the image. Given its sleek design, the RAYSCAN Alpha - Expert can fit into nearly any practice floor plan. The system's height adjustment component means patients of all sizes, including those in wheelchairs, can fit comfortably in the unit. The RAYSCAN Alpha - Expert is also the world's first imaging system to utilize a wireless remote control for patient positioning. LED lights indicate the status of the unit to practitioners at a glance: ready, standby, exposure and emergency. These components led to the RAYSCAN Alpha - Expert receiving both the red dot design award and International Design Excellence Bronze Award for its effective product design. In addition to the RAYSCAN Alpha - Expert's advanced imaging capabilities and unique design, the system also features an intuitive user interface to streamline the capture process and simplify the manipulation of images.

Health Canada recently approved the RIOSensor and also RAYSCAN's Alpha Panoramic and Cephalometric capabilities and is expected to approve RAYSCAN's cone beam computed tomography before the end of the year.

The RIOSensor, a high speed intraoral digital radiography system, will be the first offering in a range of additional product lines that LED Medical will distribute as part of the distribution agreement with Ray Co. The RIOSensor, is offered in two sizes and delivers high resolution intraoral x-ray images with resolution up to 25 lp/mm.

"We are very pleased to have negotiated an exclusive distribution agreement for Canada with Ray Co. for the RIOSensor and RAYSCAN Alpha - Expert" stated CEO Dr. David Gane. "This means that we now have distribution rights to Canada and the United States, the largest digital imaging technology market in the world. This marks yet another step for LED Medical in becoming a leading player in the digital dental imaging technology market".

"We are delighted to partner with LED Medical Diagnostics in Canada, as we already have in the U.S." stated Dr. Sangchul Lee, CEO of Ray Co. "We are confident that the superior technology of the RAYSCAN Alpha - Expert and its impressive imaging capabilities will enable it to easily take on the competition and emerge as the North American market leader".

About Ray Co., Ltd., a Subsidiary of Samsung

Since 2004, Ray Co., Ltd., has specialized in researching, developing and producing high-quality 3D computed tomography systems for the medical and dental industries. Due to outstanding x-ray technology development, Ray Co. became a subsidiary of worldwide technology leader SAMSUNG Electronics Co., Ltd, in 2010. With Samsung' s full support on design, manufacturing and quality management, Ray Co. launched the RAYSCAN Alpha - Expert in 2012. The company strives for differentiation in the dental industry through relentless R&D to deliver imaging products based on a unique design concept: simple + smart + emotional.

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiaries LED Dental Inc. and LED Dental Ltd, provide dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope® Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.

The Company is currently listed on the Toronto Stock Exchange (TSX-V) under the symbol "LMD", the OTCQX under the symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME". For more information, call 844.952.7327 or visit www.leddental.com/investor-relations.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements
This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Such forward-looking statements or information include statements regarding, but not limited to the Company's future growth strategy, its distribution strategy and product offerings, potential expansion of the Company's technology to other medical applications or markets, or the potential introduction of new technologies by the Company. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation's actual future results or performance may be materially different. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to competition risks, distributor risks, product development risks such as regulatory, design, intellectual property and other factors described in the Corporation's reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2013. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.